Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Chemotherapy-related posterior reversible leukoencephalopathy syndrome

Abstract

Background A 45-year-old woman with small-cell lung cancer presented to a hospital emergency department in an acute confusional state, with blurred vision and mild headache. Following progressively increasing lethargy, she subsequently became unresponsive to tactile and verbal stimuli. She had recently been started on chemotherapy with carboplatin and gemcitabine.

Investigations Physical examination, imaging studies including brain MRI, noncontrast brain CT scans and magnetic resonance angiography, continuous EEG monitoring, and cerebrospinal fluid analysis.

Diagnosis Posterior reversible leukoencephalopathy syndrome (PRES) related to chemotherapy, and nonconvulsive status epilepticus related to PRES.

Management Withholding of chemotherapeutic agents, and antiseizure therapy for the status epilepticus.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: MRI scans of a patient with posterior reversible leukoencephalopathy syndrome.

References

  1. Hinchey J et al. (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 334: 494–500

    Article  CAS  Google Scholar 

  2. Kozak OS et al. (2007) Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 69: 894–897

    Article  CAS  Google Scholar 

  3. Bhatt A et al. (2008) Periodic lateralized epileptiform discharges: an initial electrographic pattern in reversible posterior leukoencephalopathy syndrome. Neurol Neurochir Pol 42: 55–59

    PubMed  Google Scholar 

  4. Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 29: 1036–1042

    Article  CAS  Google Scholar 

  5. Bartynski WS and Boardman JF (2007) Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 28: 1320–1327

    Article  CAS  Google Scholar 

  6. Cooney MJ et al. (2000) Hypertensive encephalopathy: complication in children treated for myeloproliferative disorders—report of three cases. Radiology 214: 711–716

    Article  CAS  Google Scholar 

  7. Shah-Khan FM et al. (2007) Reversible posterior leukoencephalopathy syndrome and anti-neoplastic agents: a review. Oncol Rev 1: 152–161

    Article  Google Scholar 

  8. Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29: 1043–1049

    Article  CAS  Google Scholar 

  9. Gerstner ER and Fine RL (2007) Increased permeability of the blood–brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm. J Clin Oncol 25: 2306–2312

    Article  Google Scholar 

  10. Thews O et al. (2008) Activity of drug efflux transporters in tumor cells under hypoxic conditions. Adv Exp Med Biol 614: 157–164

    Article  CAS  Google Scholar 

  11. Sculier JP et al. (1987) Neurologic disorders in patients with small cell lung cancer. Cancer 60: 2275–2283

    Article  CAS  Google Scholar 

  12. Euser AG et al. (2008) Magnesium sulphate treatment decreases blood–brain barrier permeability during acute hypertension in pregnant rats. Exp Physiol 93: 254–261

    Article  CAS  Google Scholar 

  13. Rajasekhar A and George TJ Jr (2007) Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature. Oncologist 12: 1332–1335

    Article  CAS  Google Scholar 

  14. Vieillot S et al. (2007) Reversible posterior leukoencephalopathy syndrome after carboplatin therapy. Ann Oncol 18: 608–609

    Article  CAS  Google Scholar 

  15. Minami T et al. (1996) Detection of platinum in the brain of mice treated with cisplatin and subjected to short-term hypoxia. J Pharm Pharmacol 48: 505–509

    Article  CAS  Google Scholar 

  16. Horbinski C et al. (2008) Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression. AJNR Am J Neuroradiol [10.3174/ajnr.A1311]

  17. Shweiki D et al. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843–845

    Article  CAS  Google Scholar 

  18. Henderson RD et al. (2003) Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology 60: 326–328

    Article  CAS  Google Scholar 

  19. Bartynski WS and Boardman JF (2008) Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 29: 447–455

    Article  CAS  Google Scholar 

  20. Connolly RM et al. (2007) Chemotherapy induced reversible posterior leukoencephalopathy syndrome. Lung Cancer 56: 459–463

    Article  Google Scholar 

  21. Junna MR and Rabinstein AA (2007) Tacrolimus induced leukoencephalopathy presenting with status epilepticus and prolonged coma. J Neurol Neurosurg Psychiatry 78: 1410–1411

    Article  Google Scholar 

  22. van Oosterhout AG et al. (1996) Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study. Cancer 77: 1434–1441

    Article  CAS  Google Scholar 

  23. Belogolovkin V et al. (2006) Postpartum eclampsia complicated by reversible cerebral herniation. Obstet Gynecol 107: 442–445

    Article  Google Scholar 

  24. Glantz MJ et al. (1994) The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. Cancer 73: 168–175

    Article  CAS  Google Scholar 

  25. Savarese DM et al. (1996) Cerebral demyelination syndrome in a patient treated with 5-fluorouracil and levamisole. The use of thallium SPECT imaging to assist in noninvasive diagnosis—a case report. Cancer 77: 387–394

    Article  CAS  Google Scholar 

  26. Schaefer PW et al. (1997) Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 28: 1082–1085

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Désirée Lie, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the Medscape-accredited continuing medical education activity associated with this article. Written consent for publication was obtained from the patient or their responsible relative.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Archit Bhatt.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhatt, A., Farooq, M., Majid, A. et al. Chemotherapy-related posterior reversible leukoencephalopathy syndrome. Nat Rev Neurol 5, 163–169 (2009). https://doi.org/10.1038/ncpneuro1045

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro1045

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing